Hair Loss CAS 866460-33-5 bulk Setipiprant Powder

What is Setipiprant Powder ?

Setipiprant (INN) (developmental code names ACT-129,968, KYTH-105) is a drug originally developed by Actelion which acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2). It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients, it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.

Function of setipiprant powder

Setipiprant is the drug for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of Setipiprant have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery. 

Application of setipiprant powder

1. Increase cellular proliferation of outer root sheeth cells.
2. Increase hair diameter and hair density.
3. Increase the percentage of hair in the anagen phase.
4. Exert no negative effect on body hormone levels.

5. Provide equivalent or better net growth than Finasteride.

Product Name	Hair Loss CAS 866460-33-5 bulk Setipiprant Powder
Appearance	White Powder
specification	99% min
certificate	ISO 9001
Test method	HPLC
Keywords	Setipiprant hair loss,Setipiprant CAS 866460-33-5